Products

Pipeline

Oral fludarabine is a purine nucleoside analogue in registration for CLL

ASA404 is a Tumour-Vascular Disrupting Agent (Tumour-VDA) entering phase III in non-small cell lung cancer

AS1413 (amonafide malate) is a DNA intercalator in phase III in secondary AML

AS1411 is a DNA aptamer in phase II in acute myeloid leukaemia (AML)

AS1402 is a humanised monoclonal antibody entering phase II in breast cancer

AS1409 is an antibody-cytokine fusion protein in phase I clinical studies in renal cell carcinoma and melanoma

P2045 is a synthetic peptide-based targeted radiopharmaceutical in phase I studies